Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
startups
5
×
boston blog main
boston top stories
life sciences
national blog main
national top stories
san francisco blog main
biotech
deals
new york blog main
san francisco top stories
vc
boston
gene therapy
illumina
national
new york top stories
san diego blog main
san diego top stories
sanofi
spinal muscular atrophy
abiraterone
ac immune
acorda therapeutics
adeno-associated virus
aduro biotech
agenus
aldeyra therapeutics
aleksandra rizo
alexandria venture investments
alexion pharmaceuticals
alnylam pharmaceuticals
altitude life science ventures
alzheimer's disease
american society of gene and cell therapy
amy schulman
andreas klein
anna greka
apalutamide
arch venture partners
What
gene
5
×
bio
cutting
edge
human
medicine
medicines
therapies
therapy
alzheimer’s
aren’t
biopharmaceutical
called
car
celgene
cells
celularity
companies
company
create
creating
crispr
crude
derived
despite
diagnostic
diamandis
different
diseases
drug
editing
effects
encoded
endeavor
experiments
fail
fix
focus
founder
global
Language
Current search:
gene
×
startups
×
@xconomy.com
4 years ago
Encoded Nabs $104M, Illumina’s Help, to Push Gene Therapy’s Limits
@xconomy.com
5 years ago
CRISPR Diagnostic Race Heats Up as Sherlock Bio Launches With $35M
@xconomy.com
5 years ago
Bio Roundup: Alzheimer’s Fail, Drug Price Plan, Gene Therapies & More
@xconomy.com
5 years ago
CAR-T’s Launch, Payers vs. Gene Therapy & Photos From “What’s Hot”
@techcrunch.com
6 years ago
With $250 million, Peter Diamandis’ new startup is all about taking stem cells from placentas